Skip to main content

List of Targeted Therapy Drugs Approved for Specific Types of Cancer

The FDA has approved targeted therapy drugs for the treatment of some people with the following types of cancer.  Some targeted therapy drugs are listed more than once because they have been approved to treat more than one type of cancer. The generic drug name is listed first, with a brand name in parentheses.

Targeted therapy approved for bladder cancer

Targeted therapy approved for brain cancer

Targeted therapy approved for breast cancer

Targeted therapy approved for cervical cancer

Targeted therapy approved for colorectal cancer

Targeted therapy approved for dermatofibrosarcoma protuberans

Targeted therapy approved for endocrine and neuroendocrine tumors

Targeted therapy approved for endometrial cancer

Targeted therapy approved for esophageal cancer

Targeted therapy approved for head and neck cancer

Targeted therapy approved for gastrointestinal stromal tumor

Targeted therapy approved for giant cell tumor

Targeted therapy approved for kidney cancer

Targeted therapy approved for leukemia

Targeted therapy approved for liver and bile duct cancer

Targeted therapy approved for lung cancer

Targeted therapy approved for lymphoma

Targeted therapy approved for malignant mesothelioma

Targeted therapy approved for microsatellite instability-high or mismatch repair-deficient solid tumors

Targeted therapy approved for multiple myeloma

Targeted therapy approved for myelodysplastic and myeloproliferative disorders

Targeted therapy approved for neuroblastoma

Targeted therapy approved for ovarian epithelial, fallopian tube, and primary peritoneal cancers

Targeted therapy approved for pancreatic cancer

Targeted therapy approved for plexiform neurofibroma

Targeted therapy approved for prostate cancer

Targeted therapy approved for skin cancer

Targeted therapy approved for soft tissue sarcoma

Targeted therapy approved for solid tumors that are tumor mutational burden-high (TMB-H)

Targeted therapy approved for solid tumors with an NTRK gene fusion

Targeted therapy approved for stomach (gastric) cancer

Targeted therapy approved for systemic mastocytosis

Targeted therapy approved for thyroid cancer

  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “List of Targeted Therapy Drugs Approved for Specific Types of Cancer was originally published by the National Cancer Institute.”